Abstract
N’-nitrosonornicotine (NNN) is one of the tobacco-specific nitrosamines (TSNAs) that exists widely in smoke and smokeless tobacco products. NNN can induce tumors in various laboratory animal models and has been identified by International Agency for Research on Cancer (IARC) as a human carcinogen. Metabolic activation of NNN is primarily initiated by cytochrome P450 enzymes (CYP450s) via 2′-hydroxylation or 5′-hydroxylation. Subsequently, the hydroxylating intermediates undergo spontaneous decomposition to generate diazohydroxides, which can be further converted to alkyldiazonium ions, followed by attacking DNA to form various DNA damages, such as pyridyloxobutyl (POB)-DNA adducts and pyridyl-N-pyrrolidinyl (py-py)-DNA adducts. If not repaired correctly, these lesions would lead to tumor formation. In the present study, we performed density functional theory (DFT) computations and molecular docking studies to understand the mechanism of metabolic activation and carcinogenesis of NNN. DFT calculations were performed to explore the 2′- or 5′- hydroxylation reaction of (R)-NNN and (S)-NNN. The results indicated that NNN catalyzed by the ferric porphyrin (Compound I, Cpd I) at the active center of CYP450 included two steps, hydrogen abstraction and rebound reactions. The free energy barriers of the 2′- and 5′-hydroxylation of NNN are 9.82/8.44 kcal/mol (R/S) and 7.99/9.19 kcal/mol (R/S), respectively, suggesting that the 2′-(S) and 5′-(R) pathways have a slight advantage. The free energy barriers of the decomposition occurred at the 2′-position and 5′-position of NNN are 18.04/18.02 kcal/mol (R/S) and 18.33/19.53 kcal/mol (R/S), respectively. Moreover, we calculated the alkylation reactions occurred at ten DNA base sites induced by the 2′-hydroxylation product of NNN, generating the free energy barriers ranging from 0.86 to 4.72 kcal/mol, which indicated that these reactions occurred easily. The docking study showed that (S)-NNN had better affinity with CYP450s than that of (R)-NNN, which was consistent with the experimental results. Overall, the combined results of the DFT calculations and the docking obtained in this study provide an insight into the understanding of the carcinogenesis of NNN and other TSNAs.
Highlights
N’-nitrosonornicotine (NNN) is one of the tobacco-specific nitrosamines (TSNAs) widely present in tobacco products, especially in smokeless tobacco products [1]
We found that cytochrome P450 enzymes (CYP450s) 1A1, 2A6, 2A13, and 2E1 have more than one similar subchains, and their docking results were analogical, so only chain A was considered for docking
The absolute energies (AE: a.u.) and relative energies (RE: kcal/mol) for the 20 - and 50 -hydroxylation of (R)-NNN and (S)-NNN are shown in Table S1 in the Supplementary Materials
Summary
N’-nitrosonornicotine (NNN) is one of the tobacco-specific nitrosamines (TSNAs) widely present in tobacco products, especially in smokeless tobacco products [1]. NNN requires metabolic activation catalyzed by cytochrome P450 enzymes (CYP450s) to exert its carcinogenic effects [3] It has two major metabolic pathways, 20 - and 50 -hydroxylation. The α-hydroxylated NNN can spontaneous decomposition to generate diazohydroxide intermediate, followed by converting to alkyl diazonium ions, which attack the DNA base to produce DNA adducts (e.g., POB- and py-py-DNA adducts) These DNA adducts can lead to several types of DNA lesions, such as single/double-stranded breaks (SSBs/DSBs), base modifications, base mismatch, incorporation of bulky adducts during replication, and interstrand/intrastrand crosslinks (ICLs/IALs). The DFT computation was performed to investigate the metabolic activation of NNN by CYP450 iron-oxo active species Cpd I, the decomposition of 20 - and 50 -hydroxyl-NNN, and the DNA alkylation induced by the active metabolites of NNN.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
More From: International Journal of Environmental Research and Public Health
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.